Eka Ventures
VC Fund
London, United Kingdom
Eka Ventures is a VC fund in London focused on Health Care and Artificial Intelligence. Eka Ventures invests in late Seed/early Series A consumer technology companies that have a positive societal impact. This can be environmental (For example, reducing food waste) or social (For example, delivering elderly care)We are particularly fascinated with two business models: Vertically integrated direct to consumer brands, includingthose that have a logistics aspect to them Market networks We also like companies that power the two business models above We believe in the power of founders to drive this change
- Total investments:
- 36
- Last investment:
- Lead investor:
- 44%
- Fund size:
- $92M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Eka Ventures invests in
Stages Eka Ventures invests in
Countries Eka Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $2.2M–$11M
- Pre-Seed
- $1.6M–$6.7M
- Series A
- $3.3M–$21M
Investment Focus
Industry
- Health Care 5 (14%)
- Artificial Intelligence 4 (11%)
- Logistics 3 (8%)
- E-Commerce 3 (8%)
- Software 2 (6%)
Stage
- Seed 14 (39%)
- Series A 9 (25%)
- Pre-Seed 6 (17%)
- Funding Round 2 (6%)
- Venture - Series Unknown 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Camilla Dolan
Founding Partner
|
Founding Partner | Total investments: 7 | Find email | |
Jonathan Coker
General Partner & Founder
|
General Partner & Founder | Total investments: 30 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DITTO Daily
|
DITTO Daily created the Cycle Supplement to holistically address the physical and mental challenges that come with the menstrual cycle. | $6M / Seed / Jul 28, 2026 | |
Axle Energy
|
Axle's software dynamically gives flexibility to the electricity grid and adjusts energy usage to when it is cheapest and greenest. | $24M / Series A / Jul 08, 2026 | |
01Health
|
01Health is a health tech building an AI-powered clinical infrastructure platform for specialist healthcare delivery. | $15M / Series A / Jun 10, 2026 | |
Flok Health
|
Flok Health is an AI-operated digital physiotherapy platform that autonomously assesses, triages, and treats patients with musculoskeletal conditions through AI-powered virtual physiotherapy sessions. Its platform uses AI to assess patients, create personalized treatment plans, conduct interactive digital physiotherapy sessions, and manage carepathways at scale. | $12.5M / Series A / Jun 03, 2026 | |
Conveyd
|
Conveyd provides a digital conveyancing platform that supports residential property transactions by combining online workflows with regulated legal services. The platform enables users to manage buying, selling, and remortgaging processes through a single interface that handles case initiation, identity checks, document management, andcommunication with legal professionals. Conveyd uses automation and data-driven checks to streamline tasks such as onboarding, compliance verification, and progress updates, helping reduce manual steps in traditional conveyancing. Its services include online quotes, digital case tracking, and structured updates that allow customers, brokers, and partners to monitor transaction stages in real time. The company works with qualified conveyancing solicitors to prepare, review, and complete legal documentation required for property transfers. Conveyd’s offering is designed to integrate legal execution with technology-enabled transparency across the conveyancing process. | $3.3M / Seed / Dec 12, 2025 | |
|
Flok Health
|
Flok Health is an AI-operated digital physiotherapy platform that autonomously assesses, triages, and treats patients with musculoskeletal conditions through AI-powered virtual physiotherapy sessions. Its platform uses AI to assess patients, create personalized treatment plans, conduct interactive digital physiotherapy sessions, and manage carepathways at scale. | $4.2M / Pre-Seed / Nov 05, 2025 | |
Cyclana Bio
|
Cyclana Bio is to enhancing women's quality of life by offering a fresh approach to therapeutic research. They operate at the human tissue level in the data we collect and the models we build, revolutionising therapeutic discovery. | $6.7M / Pre-Seed / Oct 20, 2025 | |
Medly AI
|
Medly AI is a multilingual tutor that uses AI, theory of mind, and reinforcement learning technology to supercharge students' abilities. With Medly AI, students can engage in conversational learning, practice past exam questions, and get immediate marking and feedback. Medly AI also works with teachers to enhance the classroom, so thatstudents can have more personalized, inclusive learning experiences, and teachers can focus on what they do best - teaching.It was founded in 2023 in London, England, United Kingdom. | $2.2M / Seed / Feb 25, 2025 | |
XRlabs
|
XARlabs is transforming healthcare by delivering innovative mixed-reality technologies that improve surgical planning, medical education, and clinical collaboration. | Seed / Feb 10, 2025 | |
|
XRlabs
|
XARlabs is transforming healthcare by delivering innovative mixed-reality technologies that improve surgical planning, medical education, and clinical collaboration. | $2.3M / Pre-Seed / Feb 10, 2025 | |
| See all 36 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Eka Ventures invest in?
Eka Ventures invests primarily in Health Care, Artificial Intelligence and Logistics startups, most often at Seed and Series A stage. Most of the 36 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Eka Ventures's check size?
Eka Ventures typically joins rounds of $2.2M–$11M at Seed, $1.6M–$6.7M at Pre-Seed and $3.3M–$21M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Eka Ventures participates in.
How do I contact Eka Ventures?
Public channels for Eka Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Eka Ventures?
The team at Eka Ventures includes Camilla Dolan (Founding Partner) and Jonathan Coker (General Partner & Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
